FBIOX: Fidelity® Select Biotechnology

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

FBIOX Fidelity® Select Biotechnology

  • Fund
  • FBIOX
  • Price as of: Jan 17, 2020
  • $22.45
    - $0.11 - 0.49%

Profile

FBIOX - Profile

Vitals

  • YTD Return 1.6%
  • 3 Yr Annualized Return 6.5%
  • 5 Yr Annualized Return -0.7%
  • Net Assets $7.26 B
  • Holdings in Top 10 36.9%

52 WEEK LOW AND HIGH

$22.45
$17.96
$23.22

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.72%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 37.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA $2,500

Fund Classification


Distributions

  • YTD Total Return 1.6%
  • 3 Yr Annualized Total Return 8.5%
  • 5 Yr Annualized Total Return 2.4%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -0.20%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Fidelity® Select Biotechnology Portfolio
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Dec 16, 1985
  • Shares Outstanding
    N/A
  • Share Class
    No Load
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Rajiv Kaul

Fund Description

Fidelity Select Biotechnology Portfolio (FBIOX) is an actively managed mutual fund managed by Fidelity. The fund is focused primarily on the biotechnology industry and its operations. It is compiled primarily of U.S. common stocks in the healthcare industry with some exposure to the services industries. In general, this fund tends to have 80% of its holdings in stocks that are focused in research, development, manufacturing, and distribution of biotechnological products, services, processes and companies. The fund has been managed by Rajiv Kaul since 2005 and was launched on December 16, 1985.

The fund is very focused on capital appreciation but carries a higher amount of risk since it is sector-focused and has little diversification. The fund holds additional risk since the companies are affected by patent considerations, high competition, technological changes and government regulations. Despite its risk, the biotechnology industry is well known for its high risk and reward and may be ideal for aggressive investors seeking growth and high returns in their portfolio. In addition, sector based mutual funds such as the Fidelity Select Biotechnology Portfolio may be a good alternative for investors seeking exposure to the biotechnology industry without buying specific stocks.

Holdings in this fund are generally large cap growth stocks. The fund’s holdings are determined by analyzing drug pipelines, the size of market opportunities and the valuations. Typically, this fund holds long term growth stocks, companies with attractive drug pipelines, turnaround companies, breakthrough companies and startups.

The fund’s holdings are chosen by using various factors including financial conditions, industry position, and current economic and market conditions. This fund aims to outperform the benchmark through its active management. The fund pays dividends and capital gains every year in April and December.

This fund requires a minimum initial investment of $2,500 for both regular and IRA accounts.


Get Updates About FBIOX

Sign up for Advisor Access to receive email updates about FBIOX competitors, news, CE accredited webcasts and more.

Please Enter Your Email
Please Select Your Advisor Type

Categories

Fund Company Quick Screens

FBIOX - Fund Company Quick Screens


Performance

FBIOX - Performance

Return Ranking - Trailing

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.6% 0.0% 6.1% 73.64%
1 Yr 11.6% 2.6% 41.8% 75.63%
3 Yr 6.5%* -9.3% 27.6% 75.23%
5 Yr -0.7%* -9.8% 14.7% 76.42%
10 Yr 12.8%* -0.8% 18.8% 27.47%

* Annualized

Return Ranking - Calendar

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
2019 24.5% 5.7% 55.4% 21.85%
2018 -19.1% -25.3% 21.5% 92.79%
2017 26.1% -10.8% 43.9% 11.93%
2016 -26.2% -31.6% 6.9% 96.23%
2015 6.6% -20.4% 13.8% 9.71%

Total Return Ranking - Trailing

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.6% 0.0% 6.1% 73.64%
1 Yr 11.6% 2.6% 41.8% 75.63%
3 Yr 8.5%* -9.3% 30.8% 71.56%
5 Yr 2.4%* -9.8% 16.7% 69.81%
10 Yr 16.8%* -0.5% 18.8% 12.09%

* Annualized

Total Return Ranking - Calendar

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
2019 24.5% 5.7% 55.4% 21.85%
2018 -15.8% -25.3% 22.2% 87.39%
2017 27.9% -10.8% 45.8% 11.01%
2016 -23.8% -26.4% 8.7% 94.34%
2015 13.9% -16.6% 15.2% 4.85%

NAV & Total Return History


Holdings

FBIOX - Holdings

Concentration Analysis

FBIOX Category Low Category High FBIOX % Rank
Net Assets 7.26 B 3.58 M 48.1 B 10.24%
Number of Holdings 241 18 399 2.33%
Net Assets in Top 10 2.6 B 71.5 K 17.4 B 10.85%
Weighting of Top 10 36.86% 21.3% 75.3% 65.12%

Top 10 Holdings

  1. AbbVie Inc 10.86%
  2. Vertex Pharmaceuticals Inc 5.42%
  3. Amgen Inc 4.95%
  4. Biogen Inc 3.27%
  5. Alnylam Pharmaceuticals Inc 2.42%
  6. Gilead Sciences Inc 2.35%
  7. Neurocrine Biosciences Inc 2.01%
  8. Seattle Genetics Inc 1.88%
  9. argenx SE ADR 1.87%
  10. Sage Therapeutics Inc 1.83%

Asset Allocation

Weighting Return Low Return High FBIOX % Rank
Stocks
96.71% 48.12% 103.54% 79.84%
Other
1.97% -27.41% 5.17% 6.20%
Cash
1.10% 0.00% 51.88% 46.51%
Preferred Stocks
0.21% 0.00% 1.08% 13.18%
Convertible Bonds
0.00% 0.00% 1.54% 68.99%
Bonds
0.00% 0.00% 20.60% 65.89%

Stock Sector Breakdown

Weighting Return Low Return High FBIOX % Rank
Healthcare
100.00% 58.44% 100.00% 20.93%
Utilities
0.00% 0.00% 0.00% 62.79%
Technology
0.00% 0.00% 16.36% 75.19%
Real Estate
0.00% 0.00% 5.84% 67.44%
Industrials
0.00% 0.00% 2.40% 65.89%
Financial Services
0.00% 0.00% 6.09% 67.44%
Energy
0.00% 0.00% 0.43% 65.12%
Communication Services
0.00% 0.00% 1.02% 65.12%
Consumer Defense
0.00% 0.00% 36.20% 65.89%
Consumer Cyclical
0.00% 0.00% 10.50% 65.89%
Basic Materials
0.00% 0.00% 2.02% 71.32%

Stock Geographic Breakdown

Weighting Return Low Return High FBIOX % Rank
US
90.11% 48.12% 99.93% 18.60%
Non US
6.60% 0.00% 39.36% 81.40%

Expenses

FBIOX - Expenses

Operational Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.72% 0.10% 9.84% 92.91%
Management Fee 0.54% 0.09% 1.30% 11.63%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 95.12%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 37.00% 0.00% 341.00% 54.84%

Distributions

FBIOX - Distributions

Dividend Yield Analysis

FBIOX Category Low Category High FBIOX % Rank
Dividend Yield 0.00% 0.00% 5.20% 68.22%

Dividend Distribution Analysis

FBIOX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

FBIOX Category Low Category High FBIOX % Rank
Net Income Ratio -0.20% -2.24% 2.12% 55.91%

Capital Gain Distribution Analysis

FBIOX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

FBIOX - Fund Manager Analysis

Managers

Rajiv Kaul


Start Date

Tenure

Tenure Rank

Oct 12, 2005

14.23

14.2%

Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.59 22.31 9.83 19.68